Compare BNR & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNR | ACRE |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.6M | 254.1M |
| IPO Year | 2020 | 2012 |
| Metric | BNR | ACRE |
|---|---|---|
| Price | $21.26 | $5.04 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.33 |
| AVG Volume (30 Days) | 66.8K | ★ 551.5K |
| Earning Date | 11-20-2025 | 02-11-2026 |
| Dividend Yield | N/A | ★ 11.79% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $75,749,382.00 | ★ $87,777,000.00 |
| Revenue This Year | $136.32 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 5.56 | ★ 122.65 |
| 52 Week Low | $2.18 | $3.35 |
| 52 Week High | $24.18 | $6.32 |
| Indicator | BNR | ACRE |
|---|---|---|
| Relative Strength Index (RSI) | 56.39 | 45.57 |
| Support Level | $19.49 | $5.02 |
| Resistance Level | $24.18 | $5.55 |
| Average True Range (ATR) | 1.90 | 0.13 |
| MACD | 0.05 | -0.04 |
| Stochastic Oscillator | 56.56 | 6.60 |
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.